PAMELA GENOVESE: Open Payments
NPI 1639544158 · EAST PATCHOGUE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,113 in 122 payments from 15 companies in 2025. Trend: 2023 $1,379 · 2024 $1,559 · 2025 $2,113
Food & beverage: $2,113
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $646 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $306 |
| Madrigal Pharmaceuticals | 10 | $280 |
| PFIZER INC. | 11 | $186 |
| Ardelyx, Inc. | 8 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $152 |
| Phathom Pharmaceuticals, Inc. | 4 | $86 |
| Braintree Laboratories, Inc. | 2 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Janssen Biotech, Inc. | 3 | $51 |
Products named: RINVOQ, XIFAXAN, REZDIFFRA, IBSRELA, VELSIPITY, SKYRIZI, ENTYVIO, CREON.
Industry payments across NY — which companies pay providers there.
